CRESCENT BIOPHARMA, INC. Debt Instrument, Interest Rate, Increase (Decrease)
CRESCENT BIOPHARMA, INC. (CBIO) reported Debt Instrument, Interest Rate, Increase (Decrease) of 8.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes
us-gaap:DebtInstrumentInterestRateIncreaseDecrease · last filed 2023-03-29
- CRESCENT BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for fiscal 2022 was 8.00%, a 0.00% change from fiscal 2021.
- CRESCENT BIOPHARMA, INC. debt instrument, interest rate, increase (decrease) for fiscal 2021 was 8.00%.
| Period end | Debt Instrument, Interest Rate, Increase (Decrease) 12 month |
|---|---|
| 2022-12-31 | 8.00% 10-K · filed 2023-03-29 |
| 2021-12-31 | 8.00% 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |